The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition
Abstract
Aggregation of destabilized mutants of the tumor suppressor p53 is a major route for its loss of activity. In order to assay drugs that inhibit aggregation of p53, we established the basic kinetics of aggregation of its core domain, using the mutant Y220C that has a mutation-induced, druggable cavity. Aggregation monitored by light scattering followed lag kinetics. Electron microscopy revealed the formation of small aggregates that subsequently grew to larger amorphous aggregates. The kinetics of aggregation produced surprising results: progress curves followed either by the binding of Thioflavin T or the fluorescence of the protein at 340 nm fitted well to simple two-step sequential first-order lag kinetics with rate constants k 1 and k 2 that were independent of protein concentration, and not to classical nucleation-growth. We suggest a mechanism of first-order formation of an aggregation competent state as being rate determining followed by rapid polymerization with the higher order kinetics. By measuring the inhibition kinetics of k 1 and k 2 , we resolved that the process with the higher rate constant followed that of the lower. Further, there was only partial inhibition of k 1 and k 2 , which showed two parallel pathways of aggregation, one via a state that requires unfolding of the protein and the other of partial unfolding with the ligand still bound. Inhibition kinetics of ligands provides a useful tool for probing an aggregation mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“whereas structural mutations destabilize the DBD to various degrees, resulting in the unfolding of the mutant protein at physiological conditions, followed by rapid aggregation [11, 12].”
From Evolutionary history of the p53 family DNA-binding domain: insights from an Alvinella pompejana homolog (2022) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 1×
“Ft 1⁄4 mðk1 − k2 þ k2 expð−k1tÞ − k1 expð−k2tÞÞ∕ðk1 − k2Þ þ k3t; [2]”
Awakening guardian angels: drugging the p53 pathway
Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2763 · Cited by 881 · cited 1×
“1⁄2C t 1⁄4 1⁄2A 0ðk1 − k2 þ k2 expð−k1tÞ − k1 expð−k2tÞÞ∕ðk1 − k2Þ: [1] In practice, we fitted the data to:”
Self-citation
Research works printed but not linked: 31
- 10.1073/pnas.94.26.14338 · DOI · Paper page
- 10.1038/sj.onc.1203434 · DOI · Paper page
- 10.1038/35094077 · DOI · Paper page
- 10.1074/jbc.M302458200 · DOI · Paper page
- 10.1073/pnas.241629998 · DOI · Paper page
- 10.1073/pnas.0805326105 · DOI · Paper page
- 10.1073/pnas.0607286103 · DOI · Paper page
- 10.1016/0014-4827(91)90170-Y · DOI
- 10.1128/jvi.62.12.4737-4744.1988 · DOI
- 10.1038/292063a0 · DOI
- 10.1021/bi026635n · DOI · Paper page
- 10.1021/bi034218k · DOI · Paper page
- 10.1074/jbc.M112.340638 · DOI · Paper page
- 10.1016/0092-8674(91)90384-B · DOI · Paper page
- 10.1038/nchembio.546 · DOI · Paper page
- 10.1021/ar020073i · DOI · Paper page
- 10.1021/ja301056a · DOI · Paper page
- 10.1016/j.jmb.2006.11.008 · DOI · Paper page
- 10.1021/bi1010927 · DOI
- A Fersht Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding (W. H. Freeman, New York, 1999).
- G Wang, AR Fersht, First-order rate-determining aggregation mechanism of p53 and its implications. Proc Natl Acad Sci USA, 10.1073/pnas.1211557109. (2012). · DOI · Paper page
- 10.1110/ps.073164107 · DOI · Paper page
- 10.1073/pnas.182276099 · DOI · Paper page
- 10.1073/pnas.0501651102 · DOI · Paper page
- 10.1016/j.bpc.2011.04.006 · DOI
- 10.1021/js9801384 · DOI · Paper page
- 10.1016/j.chroma.2007.09.040 · doi:10.1016/j.chroma.2007.09.040
- 10.1110/ps.03242803 · DOI
- 10.1021/bi701899y · DOI · Paper page
- 10.1016/j.bbapap.2008.10.016 · DOI · Paper page
- 10.1073/pnas.93.1.452 · DOI · Paper page
Cited by
Muller, P. A. J., & Vousden, K. H. (2013) · Nature Cell Biology · doi:10.1038/ncb2641 · Cited by 1,647
Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
Wilcken, R., Zimmermann, M. O., Lange, A., Joerger, A. C., & Boeckler, F. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3012068 · Cited by 1,331
Self-citationThe p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
Joerger, A. C., & Fersht, A. R. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014710 · Cited by 661
Self-citationA Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
Soragni, A., Janzen, D. M., Johnson, L. M., Lindgren, A. G., Thai-Quynh Nguyen, A., Tiourin, E., Soriaga, A. B., Lu, J., Jiang, L., Faull, K. F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.002 · Cited by 341
“This approach has been successful in vitro (Bykov et al., 2002; Issaeva et al., 2003; Liu et al., 2013; Wilcken et al., 2012; Yu et al., 2012) with one molecule advancing to the clinical phase (APR-246; Lehmann et al., 2012; Khoo et al., 2014).”
BackgroundKaragöz, G. E., Acosta-Alvear, D., & Walter, P. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033886 · Cited by 310
Metadata
- Authors
- Wilcken, R., Wang, G., Boeckler, F. M., & Fersht, A. R.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-08-06
- Volume
- 109
- Issue
- 34
- Pages
- 13584-13589
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 121
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.